RxData is in attendance at the 2025 World EPA conference in Amsterdam. This year we have CEO Tommaso Albonetti following up on last year's EPA with a presentation of new research and an updated model entitled "Using G-BA assessment data to model onc...
RxData attends the 2024 World EPA conference in Amsterdam, with CEO Lawrence Monoson presenting research on "Determinants of price negotiations in Germany in the past 3 years using Machine Learning". You can find the presentation on the Intelligence...
Lawrence Monoson, CEO - RxData LUNSUMIO (mosunetuzumab): A Favorable Access Decision in Contrast to the United Kingdom ...
Overheard at ISPOR: IRA Drug Price Negotiations The 2022 Inflation Reduction Act, which aims to contain Medicare spending and improve affordability of drugs costs, was a hot topic at the recent ISPOR (International Society for Pharmac...
Purchase the book here The RxData team is thrilled to be a part of the World Evidence, Pricing and Access Congress in Amsterdam. A lot of great lec...